Vijaya Diagnostic Centre Limited has informed the Exchange about Investor Presentation
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre reported Q1 FY26 revenue of INR 1,881 Mn, up 20.4% year-on-year, driven by volume growth and improved test mix. EBITDA stood at INR 735 Mn with margins at 39.1% (marginally down 10bps YoY), while PAT grew 22.3% to INR 383 Mn with PAT margin expanding 32bps to 20.4%. The company served 1.10 Mn footfalls and performed 3.94 Mn tests across 157 centres, with Hyderabad contributing 70% of revenue. Management highlighted that all new hubs in Pune, Bengaluru, and West Bengal are operational, with the Nizamabad hub achieving break-even within just 2 quarters. The company plans to commission 3 more hubs in Q2 FY26 (Nandyal, Khammam, Kasba) and 2 additional hubs in West Bengal by H2 FY26.
Strong topline growth of 20%+ with margin stability signals healthy business momentum and successful execution of the hub-and-spoke expansion strategy. The rapid break-even at Nizamabad and aggressive hub rollout pipeline may support future revenue growth, though investors should monitor margin trends as new centres ramp up.